全文获取类型
收费全文 | 1999443篇 |
免费 | 148960篇 |
国内免费 | 4309篇 |
专业分类
耳鼻咽喉 | 29962篇 |
儿科学 | 59223篇 |
妇产科学 | 57715篇 |
基础医学 | 282127篇 |
口腔科学 | 60637篇 |
临床医学 | 172157篇 |
内科学 | 385552篇 |
皮肤病学 | 43200篇 |
神经病学 | 161194篇 |
特种医学 | 80062篇 |
外国民族医学 | 590篇 |
外科学 | 311952篇 |
综合类 | 50811篇 |
现状与发展 | 7篇 |
一般理论 | 674篇 |
预防医学 | 146192篇 |
眼科学 | 47945篇 |
药学 | 150291篇 |
4篇 | |
中国医学 | 4119篇 |
肿瘤学 | 108298篇 |
出版年
2018年 | 17429篇 |
2015年 | 17889篇 |
2014年 | 25317篇 |
2013年 | 38776篇 |
2012年 | 51128篇 |
2011年 | 53886篇 |
2010年 | 31894篇 |
2009年 | 30626篇 |
2008年 | 51636篇 |
2007年 | 56271篇 |
2006年 | 56656篇 |
2005年 | 55163篇 |
2004年 | 54026篇 |
2003年 | 52170篇 |
2002年 | 50897篇 |
2001年 | 88769篇 |
2000年 | 91194篇 |
1999年 | 77453篇 |
1998年 | 21798篇 |
1997年 | 19971篇 |
1996年 | 19284篇 |
1995年 | 18270篇 |
1994年 | 17344篇 |
1992年 | 62652篇 |
1991年 | 60709篇 |
1990年 | 59733篇 |
1989年 | 58098篇 |
1988年 | 54363篇 |
1987年 | 53567篇 |
1986年 | 51244篇 |
1985年 | 49012篇 |
1984年 | 37340篇 |
1983年 | 31759篇 |
1982年 | 19528篇 |
1981年 | 17984篇 |
1980年 | 16734篇 |
1979年 | 36775篇 |
1978年 | 26372篇 |
1977年 | 22708篇 |
1976年 | 20632篇 |
1975年 | 22990篇 |
1974年 | 27876篇 |
1973年 | 26966篇 |
1972年 | 25773篇 |
1971年 | 24063篇 |
1970年 | 22901篇 |
1969年 | 22017篇 |
1968年 | 20300篇 |
1967年 | 18505篇 |
1966年 | 17277篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
A case of Bonnet syndrome associated with blindness due to bilateral eye disease and a posterior parasagittal meningioma is reported. It is assumed that visual afferent deprivation alone is not enough to produce the syndrome and that, in most instances, a 'cerebral factor' must be operative if hallucinoses are to occur. The distinction between hallucinosis and hallucinations is favored and a common neural circuit for the mediation of hallucinotic imageries in general is suggested. One should not immediately put the blame on obvious eye or visual pathways affections when facing cases of Bonnet syndrome, as they are not likely to explain the complex array of images perceived by any given patient. On the contrary, the possibility of a clinically covert intracranial disease should be always raised and intensively looked for. 相似文献
992.
Quantitative autoradiographic analysis was used to identify regions in the brain of the male primate where androgen binding sites may be involved in the actions of testosterone. Three days after castration, adult male rhesus monkeys received a subcutaneous injection of either dihydrotestosterone propionate (DHTP, 20 mg, n = 6), testosterone propionate (TP, 100 mg, n = 2), or oil vehicle (control males, n = 4). Three hours later, 5 mCi [3H]testosterone was administered as an i.v. bolus. At 60 min, brains were rapidly removed and the left halves were used for autoradiography. In control males, highest percentages of labeled neurons (20-84% using a rigorous Poisson criterion) were observed in the ventromedial, arcuate and premammillary nuclei (n.) of the hypothalamus, medial preoptic n., bed n. of stria terminalis, intercalated mammillary n., lateral septal n. and the medial, cortical and accessory basal n. of the amygdala. Pretreatment with DHTP eliminated labeling in androgen target tissues of the genital tract, and reduced the percentages of labeled neurons to 4-22% of control values in the arcuate, lateral septal, premammillary and intercalated mammillary n., indicating that in these regions testosterone acted predominantly at androgen binding sites. However, in the medial preoptic n., the ventromedial hypothalamic n. and the accessory basal amygdaloid n., DHTP pretreatment resulted in much less blocking which, together with other data, suggested that in these sites, testosterone's actions involved aromatization and interaction with estrogen-binding sites. 相似文献
993.
994.
S. Tsagarakis Feng Ge L. H. Rees G. M. Besser A. Grossman 《Journal of neuroendocrinology》1989,1(2):129-133
While extensive evidence suggests that adrenoceptors play an important role in the control of growth hormone in the rat, there are few studies involving the direct measurement of growth hormone-releasing hormone (GHRH). We have therefore developed a radioimmunoassay for rat GHRH, and used it to investigate the modulation of GHRH release by noradrenaline from incubated rat hypothalamus in vitro. The GHRH radioimmunoassay had no significant cross-reactivity with other hypothalamic or GHRH-related peptides, and was sensitive to 4 pg/tube; intra- and interassay coefficients of variation were 6% and 12% respectively. Single incubated rat hypothalami produced a stable and readily measurable output of GHRH in successive 20 min incubations after an initial 60 min preincubation; the release of GHRH was increased in the presence of 56 mM KCI, but did not respond to KCI-depolarization when calcium was excluded from the medium. Stimulated GHRH release was identical to synthetic rat GHRH(1–43) on high-performance liquid chromatography and Sephadex G-75 chromatography.
Noradrenaline stimulated GHRH secretion in a dose-dependent manner in the concentration range 10−10 — 10−6 M, with a plateau in response at 10−7 M. Stimulation with noradrenaline 10−7 M was blocked by idazoxan 10−5 M and attenuated by thymoxamine 10−5 M, but was unaffected by timolol 10−5 M. Both the α2 -adrenoceptor agonist guanfacine, and the α1 -adrenoceptor agonist methoxamine, specifically stimulated GHRH secretion.
It is concluded that noradrenaline stimulates the release of GHRH at both α1 and α2 -adrenoceptors. 相似文献
Noradrenaline stimulated GHRH secretion in a dose-dependent manner in the concentration range 10
It is concluded that noradrenaline stimulates the release of GHRH at both α
995.
996.
This study examined longitudinal health and intelligence data to determine whether sensory or motor deficits account for some of the age-related intellectual changes that are commonly seen from midlife onward. Although sensory and motor functioning did not account for the age-related decrements in performance on speeded, visual perceptual tasks found for this sample in previous work, we did find that hearing deficits added error variance to performance estimates on two verbal subtests of the Wechsler scales. 相似文献
997.
Efficacy and toxicity of amiodarone for the treatment of supraventricular tachyarrhythmias 总被引:5,自引:0,他引:5
Amiodarone is an effective agent for all types of supraventricular tachyarrhythmias regardless of mechanism and may, in fact, control a high percentage of supraventricular tachyarrhythmias refractory to conventional antiarrhythmic agents. However, its toxicity should temper enthusiasm for the use of the medication in non-life-threatening arrhythmias. As always, when recommending specific therapies the potential benefit should be weighed in light of the related risk. In patients with life disordering, drug-refractory atrial fibrillation, it seems reasonable to attempt control with amiodarone. Likewise in patients with ectopic atrial tachycardias refractory to conventional agents, this seems reasonable as well. Other and better therapies are available for patients with life-threatening arrhythmias associated with the Wolff-Parkinson-White syndrome. While amiodarone is moderately effective in these patients, the advent of improved surgical techniques and the relatively low risk of an operation make surgery the treatment of choice. The role of IV amiodarone, acutely, in the treatment of supraventricular tachyarrhythmias remains to be defined. 相似文献
998.
Y Wada H Hasegawa H Okuda K Yoshida N Yamaguchi 《The Japanese journal of psychiatry and neurology》1989,43(2):245-253
Kindling of the primary visual cortex (VC) was compared with that of the amygdala in cats. VC kindling was basically similar to kindling of the amygdala in that daily electrical stimulation can lead to the development of a generalized convulsion in most subjects, a growth of afterdischarges in their configuration and duration, and a reduction of the afterdischarge threshold. The kindling response of the VC differed from that of the amygdala in a number of respects, i.e., a high afterdischarge threshold, a different pattern of behavioral seizure development, an abrupt growth of electroclinical seizures coincident with the onset of a generalized convulsion, an intersubject variability in seizure susceptibility, and a marked seizure instability. In VC kindling the afterdischarge propagation into the amygdala was not observed until the generalized convulsion developed, and the early involvement of afterdischarge was seen in the pulvinar, lateral geniculate body, and superior colliculus. These data suggest that a neural mechanism different from amygdaloid kindling may participate in VC kindling, and that the subcortical structures of the visual system are involved in the preferential pathway for a seizure generalization from the VC. 相似文献
999.
1000.
The pharmacology of dichloroacetate 总被引:18,自引:0,他引:18
P W Stacpoole 《Metabolism: clinical and experimental》1989,38(11):1124-1144
Dichloroacetate (DCA) exerts multiple effects on pathways of intermediary metabolism. It stimulates peripheral glucose utilization and inhibits gluconeogeneis, thereby reducing hyperglycemia in animals and humans with diabetes mellitus. It inhibits lipogenesis and cholesterolgenesis, thereby decreasing circulating lipid and lipoprotein levels in short-term studies in patients with acquired or hereditary disorders of lipoprotein metabolism. By stimulating the activity of pyruvate dehydrogenase, DCA facilitates oxidation of lactate and decreases morbidity in acquired and congenital forms of lactic acidosis. The drug improves cardiac output and left ventricular mechanical efficiency under conditions of myocardial ischemia or failure, probably by facilitating myocardial metabolism of carbohydrate and lactate as opposed to fat. DCA may also enhance regional lactate removal and restoration of brain function in experimental states of cerebral ischemia. DCA appears to inhibit its own metabolism, which may influence the duration of its pharmacologic actions and lead to toxicity. DCA can cause a reversible peripheral neuropathy that may be related to thiamine deficiency and may be ameliorated or prevented with thiamine supplementation. Other toxic effects of DCA may be species-specific and reflect marked interspecies variation in pharmacokinetics. Despite its potential toxicity and limited clinical experience, DCA and its derivatives may prove to be useful in probing regulatory aspects of intermediary metabolism and in the acute or chronic treatment of several metabolic disorders. 相似文献